跳至主要内容
临床试验/JPRN-UMIN000012025
JPRN-UMIN000012025已完成2 期

Phase 2 study of carboplatin and weekly nab-paclitaxel for elderly squamous cell lung cancer - Phase 2 study of CBDCA and weekly nab-PTX for elderly squamous cell lung cancer

Osaka City General Hospital0 个研究点目标入组 35 人开始时间: 2013年10月11日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
75years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)With active other organ cancer 2)With active infection 3)With fever equal to or more than 38C 4)With mental disorder 5)With symptomatic brain metastasis 6)Pleural and peritoneal effusion likely to require surgical intervention,or pericardial effusion 7) Systematic steroids , immunosuppressive medication or poorly controlled diabetes 8)Grade 2 or higher peripheral neuropathy 9)Radiographically confirmed interstitial pneumonitis or pulmonary fibrosis 10)poorly controlled hypertension 11)Ischemic heart disease or cardiac infarction within 6 months before enrollment 12)History of severe drug allergies 13)Physician concludes that the patient's participation in this trial is inappropriate

研究者

相似试验

Phase 2 study of carboplatin and weekly... | 临床试验